|View printer-friendly version|
|January 24, 2003 4:32 p.m.|
|Teva Announces Final Approval of Mirtazapine 15mg, 30mg 180-day Marketing Exclusivity|
Jerusalem, Israel, January 24, 2003 - Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that the U.S. Food and Drug Administration (FDA) has granted final approval for the company's Mirtazapine Tablets, 15 mg and 30 mg. Shipment will begin immediately.